Relation between TP53 GOF mutation and Osimertinib treatment in EGFR mutant lung cancer
Ontology highlight
ABSTRACT: Relation between TP53 GOF mutation and Osimertinib treatment in EGFR mutant lung cancer
PROVIDER: PRJNA974376 | ENA |
REPOSITORIES: ENA
ACCESS DATA